Corstasis Scores FDA Nod for Nasal Spray Treatment
16 Sep 2025 //
FIERCE PHARMA
Corstasis Therapeutics Appoints Dr. Amin as VP of Medical Affairs
11 Sep 2025 //
PHARMAWEB
Corstasis Gets Patent and Updates on RSQ-786 and RSQ-789 Programs
03 Sep 2025 //
BUSINESSWIRE
Corstasis Therapeutics Appoints Sanjeev Narula to Advisory Board
23 Jul 2025 //
BUSINESSWIRE
Corstasis to Present Bumetanide Nasal Spray Data at AHA Sessions
15 Nov 2024 //
BUSINESSWIRE